Toronto Dominion Bank Sells 25,716 Shares of CME Group Inc. (NASDAQ:CME)

Toronto Dominion Bank reduced its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 11.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 208,849 shares of the financial services provider's stock after selling 25,716 shares during the period. Toronto Dominion Bank owned about 0.06% of CME Group worth $48,300,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its position in CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after buying an additional 326,623 shares during the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after acquiring an additional 104,697 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the period. Norges Bank acquired a new stake in CME Group in the fourth quarter worth about $1,107,389,000. Finally, FIL Ltd raised its holdings in CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after purchasing an additional 61,908 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

Shares of CME traded up $3.13 during trading hours on Friday, reaching $289.00. The stock had a trading volume of 4,437,323 shares, compared to its average volume of 2,195,335. The stock has a market capitalization of $104.14 billion, a PE ratio of 29.89, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $291.36. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The company's 50-day moving average is $269.47 and its two-hundred day moving average is $250.66.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the previous year, the business posted $2.50 earnings per share. The business's quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.73%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Bank of America lifted their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Morgan Stanley lifted their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research note on Monday, March 10th. Finally, Oppenheimer increased their target price on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday, April 11th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus target price of $256.80.

Insider Buying and Selling at CME Group

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares in the company, valued at $5,686,980. This represents a 31.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,400 shares of company stock worth $6,533,180. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.